Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years.
Read MoreThe latest on the markets
Jim Cramer prepares investors for the Fed to raise interest rates and shares his top rules for short selling in a low-growth environment.
Evercore's Ken Sena and Citi's Mark May explain why LinkedIn's stock is down despite its latest earnings beat.
Fighting the Fed is a losing battle. Jim Cramer explains why.
Raoul Pal of "The Global Macro Investor" and Real Vision TV explains why Europe could be heading for a recession.